About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 739029, 11 pages
http://dx.doi.org/10.1155/2013/739029
Review Article

Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials

1Shanghai Public Health Clinical Center Affiliated to Fudan University, Department of Traditional Chinese Medicine, No. 2901 Caolang Road, Jinshan District, Shanghai 201508, China
2Shanghai Medical College, Fudan University, Department of Oncology, Shanghai 200032, China
3Shanghai Cancer Center, Department of Integrative Medicine, Shanghai 200032, China
4The Central Hospital of China Aerospace Corporation, Beijing 100049, China

Received 29 December 2012; Revised 26 February 2013; Accepted 17 March 2013

Academic Editor: Fabio Marra

Copyright © 2013 Zongguo Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Zongguo Yang, Liping Zhuang, Lei Yang, and Xiaorong Chen, “Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials,” Gastroenterology Research and Practice, vol. 2013, Article ID 739029, 11 pages, 2013. doi:10.1155/2013/739029